Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer
出版年份 2023 全文链接
标题
Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer
作者
关键词
-
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 115925
出版商
Elsevier BV
发表日期
2023-11-07
DOI
10.1016/j.ejmech.2023.115925
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rezvilutamide: First Approval
- (2023) Susan J. Keam DRUGS
- Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
- (2022) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Second generation androgen receptor antagonists and challenges in prostate cancer treatment
- (2022) Yanhua Chen et al. Cell Death & Disease
- Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
- (2022) Weijie Gu et al. LANCET ONCOLOGY
- Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
- (2021) Wanxiao Sun et al. JOURNAL OF CONTROLLED RELEASE
- Piflufolastat F 18: Diagnostic First Approval
- (2021) Susan J. Keam Molecular Diagnosis & Therapy
- Advances in PSMA-targeted therapy for prostate cancer
- (2021) Fujin Wang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Obesity and prostate cancer: A narrative review
- (2021) Rebekah L. Wilson et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Influence of Diet and Nutrition on Prostate Cancer
- (2020) Makoto Matsushita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent progress in treating advanced prostate cancer
- (2020) Theodore Gourdin CURRENT OPINION IN ONCOLOGY
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
- (2020) Neal D. Shore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies
- (2020) Lucas Nogueira et al. MOLECULES
- FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA ‐Mutated Metastatic Castrate‐Resistant Prostate Cancer
- (2020) Mitchell S. Anscher et al. ONCOLOGIST
- The evolving role of diet in prostate cancer risk and progression
- (2019) Adeel Kaiser et al. CURRENT OPINION IN ONCOLOGY
- Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer
- (2019) Irena Saarinen et al. EJNMMI Research
- Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects
- (2019) Carlos Pérez-Ruixo et al. CLINICAL PHARMACOKINETICS
- Darolutamide: First Approval
- (2019) Anthony Markham et al. DRUGS
- PARP Inhibition in Cancer: An Update on Clinical Development
- (2019) Esha Sachdev et al. Targeted Oncology
- Role of chemotherapy in prostate cancer
- (2018) JeannyB Aragon-Ching et al. ASIAN JOURNAL OF ANDROLOGY
- Apalutamide: First Global Approval
- (2018) Zaina T. Al-Salama DRUGS
- Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
- (2018) Karim Fizazi et al. Clinical Genitourinary Cancer
- Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
- (2017) LE Dockery et al. OncoTargets and Therapy
- Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
- (2016) Matthew R. Smith et al. EUROPEAN UROLOGY
- Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy
- (2016) Zachary B Jenner et al. Future Oncology
- Cabazitaxel and indocyanine green co-delivery tumor-targeting nanoparticle for improved antitumor efficacy and minimized drug toxicity
- (2016) Xiaowei Tai et al. JOURNAL OF DRUG TARGETING
- The role of the prostate in male fertility, health and disease
- (2016) Paolo Verze et al. Nature Reviews Urology
- TCDA: Practical Synthesis and Application in the Trifluoromethylation of Arenes and Heteroarenes
- (2016) Jian Wang et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Diagnostic and Therapeutic Strategies for Prostate Cancer
- (2016) Mary Nguyen-Nielsen et al. SEMINARS IN NUCLEAR MEDICINE
- The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
- (2016) Reem T. Attia et al. PeerJ
- Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
- (2015) Jack Schalken et al. BJU INTERNATIONAL
- ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
- (2015) Karim Fizazi et al. Expert Review of Anticancer Therapy
- Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent
- (2015) Bing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- CYP17A1 inhibitors in castration-resistant prostate cancer
- (2015) Lissette Gomez et al. STEROIDS
- Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
- (2015) Anu-Maarit Moilanen et al. Scientific Reports
- Androgen receptor: structure, role in prostate cancer and drug discovery
- (2014) MH Eileen Tan et al. ACTA PHARMACOLOGICA SINICA
- Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
- (2014) MarkN Stein et al. ASIAN JOURNAL OF ANDROLOGY
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Androgen receptor antagonists for prostate cancer therapy
- (2014) Christine Helsen et al. ENDOCRINE-RELATED CANCER
- An Efficient Semi-Synthetic Method to Construct Docetaxel via Sterically Crowded Linear Side Chain Esterification
- (2013) Xin Shen et al. CHINESE JOURNAL OF CHEMISTRY
- The New Promise of FACBC Position Emission Tomography/Computed Tomography in the Localization of Disease Relapse After Radical Treatment for Prostate Cancer: Are We Turning to the Right Radiotracer?
- (2013) Riccardo Schiavina et al. EUROPEAN UROLOGY
- Advances in Androgen Receptor Targeted Therapy for Prostate Cancer
- (2013) Alia Ahmed et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Process Development of C–N Cross-Coupling and Enantioselective Biocatalytic Reactions for the Asymmetric Synthesis of Niraparib
- (2013) Cheol K. Chung et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation
- (2012) Akiyoshi Miwa et al. AMERICAN JOURNAL OF HEMATOLOGY
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor
- (2012) Adam T. Gillmore et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer
- (2011) D. J. Osguthorpe et al. BIOCHEMISTRY
- The role of PARP in DNA repair and its therapeutic exploitation
- (2011) M Javle et al. BRITISH JOURNAL OF CANCER
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- Cabazitaxel
- (2011) Cristian Villanueva et al. DRUGS
- The Role of Abiraterone Acetate in the Management of Prostate Cancer: A Critical Analysis of the Literature
- (2011) Guru Sonpavde et al. EUROPEAN UROLOGY
- Romidepsin: a novel histone deacetylase inhibitor for cancer
- (2011) Erin M Bertino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor
- (2011) Kazuhiro Miwa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Abiraterone acetate
- (2011) Christopher J. Logothetis et al. NATURE REVIEWS DRUG DISCOVERY
- Development of a Fit-for-Purpose Large-Scale Synthesis of an Oral PARP Inhibitor
- (2011) Debra J. Wallace et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- One Step Radiosynthesis of 6-[18F]Fluoronicotinic Acid 2,3,5,6-Tetrafluorophenyl Ester ([18F]F-Py-TFP): A New Prosthetic Group for Efficient Labeling of Biomolecules with Fluorine-18
- (2010) Dag E. Olberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
- (2010) Michael E. Jung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
- (2009) R. A. Daniel et al. CLINICAL CANCER RESEARCH
- Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
- (2009) Todd Morgan et al. CURRENT CANCER DRUG TARGETS
- The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research*
- (2009) F. Neumann EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors
- (2009) Philip Jones et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)
- (2008) Sangeeta R. Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
- (2008) Keith A. Menear et al. JOURNAL OF MEDICINAL CHEMISTRY
- Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines
- (2008) Anders Ullén et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now